Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase IV study of oral propranolol solution for proliferating infantile hemangioma
ChiCTR2300067478Phase 4Not yet recruiting
- Sponsor
- Beijing Children's Hospital
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of propranolol in Capillary Haemangioma, sponsored by Beijing Children's Hospital. Primary endpoint: Recovery rate. Planned start Oct 2022; status: not yet recruiting.
02
Drugs
propranolol
03
Conditions
Capillary Haemangioma
Beyond the preview
Go deeper on ChiCTR2300067478.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067478.